Elogia acquires IDE360 to strengthen Elogia Pharma division

BHH member Elogia, an agency from the VIKO group specialized in Digital Commerce Marketing, has announced the acquisition of 100% of IDE360, a company specializing in pharmaceutical and health industry marketing with a team of 18 people who will integrate into Elogia, and an EBITDA of over 500,000 euros. This strategic operation aims to primarily strengthen and expand the Elogia Pharma division, striving for market leadership.

IDE360, founded and led by Eva Velasco, offers a unique value proposition that combines strategy, creativity, and omnichannel approaches, allowing its clients to close the loop in pharmaceutical marketing. Their 360º service offering includes everything from brand strategy to creative omnichannel campaigns for healthcare professionals, pharmacies, consumers, and patients.

With over 13 years supporting the pharmaceutical business, IDE360 has deep and specialized knowledge in various sector areas, including Rx, OTC, parapharmacy, medical devices, dietary supplements, biosimilars, rare diseases, and animal health. This extensive experience has enabled them to become a strategic partner for leading industry companies such as Esteve, Elanco, Chiesi, Reig Jofre, Zambon, Kern Pharma, and Angelini Pharma.

"This merger between Elogia Pharma and IDE360 represents a clear advancement in continuing to support our clients in developing their brands and businesses. We are combining an extraordinary and committed group of professionals to enhance our capabilities and offer innovative and effective solutions to our clients. Together, we will consolidate our position as market leaders, developing marketing strategies that make a difference," explained Eva Velasco, founder and General Manager of IDE360.

A Strategic Union for Elogia

The integration of IDE360 into Elogia Pharma will result in a unique synergy, combining IDE360's specialized knowledge and extensive experience with Elogia's vast digital marketing expertise. Eva Velasco and Josep Soldevila, IDE360's Operations Director, will join to support the new team with their proven experience within the sector. All of this will translate into a more robust and strategic service offering, benefiting clients with more effective marketing campaigns focused on return on investment.

"At Elogia Pharma, we are delighted to welcome the entire IDE360 team and talent. The fusion of our strengths will allow us to provide more comprehensive and innovative solutions to the pharmaceutical industry, reinforcing our market leadership and significantly benefiting our clients," assured Anna Serrano, Director of Elogia Pharma.